Atrial fibrillation (AF) is the most common form of arrhythmia, affecting 4 in 100 people over 65.
It affects 1 million people in the UK and is associated with 1:8 strokes (1:3 in people 80+). More than 50% could be averted by oral medicines called anticoagulants (OACs). However, the proportion of patients receiving OACs varies.
We examined the determinants of why anticoagulation varies between GPs, and implemented intervention programmes to improve medicines optimisation.